4-Chloro-6-methoxy-2-(propylthio)-5-pyrimidinamine-d3 is labelled 4-Chloro-6-methoxy-2-(propylthio)-5-pyrimidinamine (C369935) which is an intermediate used in the syntehsis of ticagrelor (T437700), the first reversible oral P2Y12 receptor antagonist.